Episode 32: Cannabis As a Treatment Option

This episode features an interview with Dr. Uma Dhanabalan, as she discusses the use of cannabis as a treatment option for Lyme patients and those with chronic illness. She also shares her thoughts about the stigma and laws around the medical use of cannabis and some of the biggest misconceptions about this field.

Dr. Dhanabalan is a highly respected physician trained in Family Medicine, Occupational & Environmental Medicine, a Fellow of the American Academy of Family Physicians and a Diplomate of American Academy of Cannabinoid Medicine.

She received her medical degree from the University of Medicine & Dentistry of Newark, New Jersey, Family Practice Residency at the Medical University of South Carolina, Her Master’s in Public Health, Occupational & Environmental Medicine Residency and Fellowship in heavy metals at the Harvard School of Public Health She has received awards from the American College of Occupational & Environmental Medicine for her research project: “Occupational & Environmental Exposure to Lead in South India.” and from The 7th World Ayurveda Conference & Arogya Expo for presentation “Cannabis & The Therapeutic Uses”

She worked for Kimberly Clark as Regional Medical Director for Asia Pacific. She is the Founder/CEO for Global Health & Hygiene Solutions, LLC established in 2006, with a mission to promote wellness and prevent illness. She worked for the Hanford Site in Richland, Washington, the largest and most complex cleanup projects in the world, where plutonium was manufactured for the first nuclear bomb detonated in Japan.

She practices TotalHealthCare at Uplifting Health and Wellness, in Natick, Massachusetts, where she “Educates Embraces Empowers” her patients and promotes cannabis as a treatment option She is an advocate, activist and educator and speaks globally about cannabis as a plant medicine. Dr Dhanabalan states “Cannabis is not for everyone, yet is should be a first line option not the last resort” and “Cannabis is not an entrance drug, it is an exit drug from pharmaceuticals narcotics and alcohol.”